Trinity Biotech Provides an Update on the Continued Development of Its Continuous Glucose Monitor Technology
TRIBTrinity Biotech(TRIB) GlobeNewswire News Room·2024-09-10 04:05

DUBLIN, Ireland, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a commercialstage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today provided an update on the continued development of its glucose biosensor technology. Earlier this year Trinity Biotech was granted a European patent (EP3703565) for a novel method that enhances the performance of an indwelling sensor, such as a glucose biosensor. Recent testing of t ...